Shanghai Ruijin Hospital recently announced that its multidisciplinary team has successfully completed the 100th high-difficulty combined endocrine and hematologic surgery, marking the hospital's clinical experience in this interdisciplinary field as leading nationwide. These surgeries involved complex cases such as pituitary tumors with hematologic abnormalities and hyperparathyroidism with myelofibrosis, achieving an overall success rate of over 98%.
The diagnostic and treatment center jointly established by the Department of Endocrinology and the Department of Hematology at Ruijin Hospital adopts a full-process model including precise preoperative phenotyping, intraoperative multidisciplinary collaboration, and postoperative individualized management. Taking the latest 100th surgery as an example, the patient was a 52-year-old male with refractory Cushing's syndrome complicated by coagulation dysfunction. The team successfully resected the lesion while preserving normal pituitary function using molecular pathology testing and intraoperative navigation technology.
Background and Significance
Endocrine diseases and hematologic disorders often interact; for instance, Cushing's syndrome can lead to a hypercoagulable state, while treatments for hematologic malignancies may cause endocrine disturbances. Traditional single-specialty treatment often addresses one issue at the expense of the other, but Ruijin Hospital's combined surgery model fills this gap. Since the program's inception in 2019, surgical indications have gradually expanded to cover synergistic lesions of endocrine organs such as the pituitary, thyroid, and adrenal glands, along with hematologic tissues like the bone marrow and lymphatic system. Hospital statistics show that the postoperative complication rate has decreased by 35% compared to single-specialty surgeries, and the average hospital stay has been shortened by 4.2 days.
Significance for International Patients
For international patients, Ruijin Hospital's experience means safer treatment options. Many patients face cumbersome multi-department referral processes in their home countries, whereas Ruijin Hospital offers one-stop multidisciplinary care and clarifies surgical feasibility through remote consultations during the case evaluation phase. Additionally, the hospital provides bilingual case managers for overseas patients to assist with visa, accommodation, and follow-up arrangements.
How MedCare Can Help
MedCare, as a cross-border medical platform, can assist international patients in scheduling appointments at Ruijin Hospital's combined endocrine-hematology clinic and provide detailed information on cost estimation and medical services. We have established a green channel with Ruijin Hospital to prioritize expert consultations for complex cases. If you or a loved one faces similar health challenges, feel free to contact us for personalized treatment plans.
Related reading: Overview of Shanghai Partner Hospitals